Clik here to view.
ヒト軟骨細胞の老化を逆転、若さを取り戻す 初の偉業に江戸川病院（東京）が成功
東京 （ビジネスワイヤ） — 加齢による摩耗、怪我、変形性関節症等で損傷した膝関節の軟骨は、関節置換手術の際に取り除かれ廃棄されています。しかし、この軟骨が、細胞の老化を逆転させる画期的な技術（老化関連の β- ガラクトシダーゼ、p16、p21マーカーにより確認）によって若返り、細胞治療に利用できるという論文がNature誌のScientific Reports...
View ArticleClik here to view.
KANEKA CORPORATION: Sales Expansion of Brain Aneurysm Embolization Coils in...
TOKYO Kaneka Corporation (TOKYO: 4118) (Headquarters: Minato-ku, Tokyo; President: Minoru Tanaka) received U.S.-FDA*1approval in April 2020 for its new brain aneurysm Embolization Coil*2 (product...
View ArticleClik here to view.
Clik here to view.
Kyalio率先发表亚洲唯一Day-to-Day内视镜/腹腔镜虚拟现实手术案例数据库
新加坡 (美国商业资讯)–Kyalio于7月1日与亚洲内视镜与腹腔镜外科医学会(ELSA, the Endoscopic and Laparoscopic Surgeons of...
View ArticleClik here to view.
PolarityTE Receives Notice of Allowance for Chinese Patent
SALT LAKE CITY PolarityTE, Inc. (Nasdaq: PTE) today announced that the China National Intellectual Property Administration (CNIPA) issued a Notification of Allowance for Chinese Patent Application...
View ArticleClik here to view.
Aurion Biotech Appoints Professor Shigeru Kinoshita, MD, PhD, to Its Medical...
SEATTLE & BOSTON & TOKYO Shigeru Kinoshita, MD, PhD, has joined the medical advisory board at Aurion Biotech, whose mission is to cure blindness by developing a differentiated platform of...
View ArticleClik here to view.
Patented Thread Lifting ‘TIMEMACHINE LIFT ANCHORING DUAL COG’ Proven to...
SEONGNAM, South Korea SENSCO, a Korean professional medical device Thread Lift manufacturing company, said that its thread lifting, TIMEMACHINE LIFT ANCHORING DUAL COG (https://timemachinelift.com/)...
View ArticleClik here to view.
Brain Mapping Pioneer Omniscient Neurotechnology Raises AUD 40 Million in...
SYDNEY Omniscient Neurotechnology (“o8t™”), a pioneering brain mapping technology company, today announced the completion of an AUD 40 million Series B financing round. The funding was led by family...
View ArticleClik here to view.
Aurion Biotech Announces IOTA Cell Therapy Trial
SEATTLE & BOSTON & TOKYO Aurion Biotech, whose mission is to cure blindness by developing a differentiated platform of advanced therapies to treat ocular diseases, today announced...
View ArticleClik here to view.
Wyss中心与Artiria Medical合作加速脑血管痉挛的新型疗法
日内瓦 (美国商业资讯)–Wyss中心(Wyss Center)和Artiria Medical今天宣布建立新的合作伙伴关系，以加速一项新技术的转化。该技术有望降低卒中患者的死亡率并提高其生活品质。Artiria...
View ArticleClik here to view.
Clik here to view.
株式会社KORTUCはピボタル第II相試験（革新的ながん治療放射線増感剤）の加速にむけ、アクサ生命より資金調達を実施
ロンドン & ニューヨーク & 東京 （ビジネスワイヤ） — がんの放射線治療効果を高める放射線増感剤KORTUCの臨床開発及び製品開発を行なうスタートアップ企業、株式会社KORTUC（以下 KORTUC）はアクサ生命保険株式会社（以下 アクサ生命）からの資金調達を実施しました。 KORTUCは本資金調達により、英国で実施中の承認申請取得の為の試験（以下...
View ArticleClik here to view.
KORTUC Inc. Closed Financing From AXA Japan to Accelerate Pivotal Phase II...
LONDON & NEW YORK & TOKYO Today KORTUC Inc., a Japanese clinical-stage biopharmaceutical company focusing on the clinical and product development of a novel radiosensitizer improving the...
View ArticleClik here to view.
Pillar Biosciences Appoints Dr. Eric Lai to its Board of Directors
NATICK, Mass. & SHANGHAI Pillar Biosciences, an innovative next-generation sequencing (NGS) solutions in-vitro diagnostics (IVD) company, today announced the appointment of Eric Lai, Ph.D. to...
View ArticleClik here to view.
Advanced Clinical’s Graham Belgrave Named to the 2021 PharmaVOICE 100 List of...
DEERFIELD, Ill. Graham Belgrave, Senior Vice President of European Operations at Advanced Clinical, has been recognized by PharmaVOICE magazine as a distinguished leader on the 2021 PharmaVOICE 100...
View ArticleClik here to view.
Daniela Drago Joins Aurion Biotech as Chief Regulatory Officer
SEATTLE & BOSTON & TOKYO Aurion Biotech, whose mission is to cure blindness by developing a differentiated platform of advanced therapies to treat ocular diseases, today announced it has...
View ArticleClik here to view.
Real-World Data Shows Aroa Biosurgery’s Endoform™ Natural Achieves...
AUCKLAND, New Zealand A new retrospective study of real-world data (‘RWD’) has shown significantly improved wound closure times for diabetic foot ulcers (‘DFU’) and much greater probability of wound...
View ArticleClik here to view.
PhaseBio Pharmaceuticals Achieves Enrollment Milestones Supporting Interim...
MALVERN, Pa. & SAN DIEGO PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapies for...
View ArticleClik here to view.
Dubai is Open for Business: Aster Hospitals Welcome Medical Travelers from...
DUBAI, United Arab Emirates & MALÉ, Maldives Aster DM Healthcare, one of the largest private global healthcare service providers with 365 total healthcare facilities worldwide, including seven...
View ArticleClik here to view.
Harrow Health Acquires Ophthalmic Surgical Drug Candidate From Wakamoto...
NASHVILLE, Tenn. & TOKYO Harrow Health, Inc. (NASDAQ: HROW), an ophthalmic‑focused healthcare company, today announced that it has entered into an agreement with Wakamoto Pharmaceutical Co.,...
View Article